“FDA Approves Zepbound: A Game-Changer for Obstructive Sleep Apnea and Weight Loss!”
Eli Lilly Says FDA Approves Zepbound for Obstructive Sleep Apnea in Adults With Obesity – WSJ On December 20, 2024, the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and …